| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 363607-99-2 | Imidazo[1,2-a]pyridin-8(5H)-one,6,7-dihydro-2-methyl-; 2-Methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-one; 2-Methyl-6,7-dihydro-5H-imidazo[1,2-a]pyridin-8-one |  | C8H10N2O | 詳情 | 供應商 | |
| 87224-89-3 | Indium,trimethyl(triethylphosphine)-, (T-4)-; trimethyl(triethylphosphine)indium |  | C9H24InP | 詳情 | 供應商 | |
| 294662-09-2 | Imidazo[1,2-b][1,2,4]triazolo[4,3-d][1,2,4]triazine(9CI); Imidazo[1,2-b][1,2,4]triazolo[4,3-d][1,2,4]triazine (9CI) |  | C6H4N6 | 詳情 | 供應商 | |
| 297172-19-1 | Imidazo[1,5-a]pyrazine,5,6,7,8-tetrahydro-; Imidazo[1,5-a]pyrazine, 5,6,7,8-tetrahydro- (9CI) |  | C6H9N3 | 詳情 | 供應商 | |
| 294880-84-5 | Imidazo[1,2-a]pyrimidin-2(3H)-one,1,5-dihydro-5-thioxo-7-(trifluoromethyl)-; Imidazo[1,2-a]pyrimidin-2(3H)-one, 1,5-dihydro-5-thioxo-7-(trifluoromethyl)- |  | C7H4F3N3OS | 詳情 | 供應商 | |
| 66536-80-9 | Inosine, 5'-(hydrogen1H-imidazol-1-ylphosphonate) (9CI); ImpI |  | C13H15N6O7P | 詳情 | 供應商 | |
| 70474-55-4 | Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3-thienylmethyl)-, hydrochloride (1:1); Isoquinoline,1,2,3,4-tetrahydro-6,7-dimethoxy-1-(3-thienylmethyl)-, hydrochloride (9CI); NSC345766 |  | C16H20ClNO2S | 詳情 | 供應商 | |
| 76919-45-4 | Imidazo[2,1-b]thiazole-5-methanol,6-chloro-, 5-acetate; Imidazo[2,1-b]thiazole-5-methanol,6-chloro-, acetate (ester) (9CI); NSC 332697 |  | C8H7ClN2O2S | 詳情 | 供應商 | |
| 130946-69-9 | Indeno[1,2-c]pyrazole,1-(6-chloro-4-methyl-2-quinolinyl)-1,4-dihydro-3-methyl- |  | C21H16ClN3 | 詳情 | 供應商 | |
| 36982-71-5 | Isoquinoline,5,6,7-trimethoxy-; 5,6,7-Trimethoxyisoquinoline; Isonortehuanine |  | C12H13NO3 | 詳情 | 供應商 | |
| 36944-99-7 | Indolizine,5-methyl-2-phenyl-; 5-Methyl-2-phenylindolizine |  | C15H13N | 詳情 | 供應商 | |
| 20688-71-5 | Imidazole-5-carboxylicacid, 4-nitro-1-b-D-ribofuranosyl-,methyl ester, 2',3',5'-triacetate (8CI); NSC113953 |  | C16H19N3O11 | 詳情 | 供應商 | |
| 270902-47-1 | Imidazo[1,2-a]pyrazin-5(1H)-one; Imidazo[1,2-a]pyrazin-5(1H)-one (9CI) |  | C6H5N3O | 詳情 | 供應商 | |
| 36548-61-5 | Iron, acetylcarbonyl(h5-2,4-cyclopentadien-1-yl)(triphenylphosphine)-,stereoisomer (9CI); IRON ACETYL CHIRAL; IRON ACETYL COMPLEX (-)-(R)-ENANTIOMER; IRON ACETYL COMPLEX (+)-(S)-ENANTIOMER; (R)-(-)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON; (R)-(-)-ACETYLCARBONYL((ETA)5-2,4-CYCLOPENTADIENE-1-YL)(TRIPHENYLPHOSPHINE)IRON; (R)-(-)-ACETYLCYCLOPENTADIENYLIRONCARBONYLTRIPHENYLPHOSPHINE COMPLEX; (S)-(+)-ACETYLARBONYL((ETA)5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON; (S)-(+)-ACETYLCARBONYL(ETA5-2,4-CYCLOPENTADIEN-1-YL)(TRIPHENYLPHOSPHINE)IRON |  | C26H23FeO2P | 詳情 | 供應商 | |
| 276879-69-7 | Imidazo[1,2-a]pyrazin-3(7H)-one,6-(4-hydroxyphenyl)-2-[(4-methoxyphenyl)methyl]-8-(phenylmethyl)-; Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(4-hydroxyphenyl)-2-[(4-methoxyphenyl)methyl]-8-(phenylmethyl)- |  | C27H23N3O3 | 詳情 | 供應商 | |
| 72989-11-8 | Ibogamine-18-carboxylicacid, 13-[(3,4-dimethoxyphenyl)methyl]-12-methoxy-, methyl ester (9CI); 6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,ibogamine-18-carboxylic acid deriv.; 13-(3,4-Dimethoxybenzyl)voacangine; NSC285230 |  | C31H38N2O5 | 詳情 | 供應商 | |
| 274930-80-2 | Imidazolidine,4-butyl-, (4S)-; Imidazolidine, 4-butyl-, (4S)- (9CI) |  | C7H16N2 | 詳情 | 供應商 | |
| 274930-79-9 | Imidazolidine,4-butyl-, (4R)-; Imidazolidine, 4-butyl-, (4R)- (9CI) |  | C7H16N2 | 詳情 | 供應商 | |
| 36207-55-3 | Imidazo[1,2-c]pyrimidin-5(6H)-one,6-b-D-ribofuranosyl-,monohydrochloride (9CI); 5,6-Dihydro-5-oxo-6-b-D-ribofuranosylimidazo[1,2-c]pyrimidinehydrochloride; Ethenocytidine hydrochloride |  | C11H14ClN3O5 | 詳情 | 供應商 | |
| 269402-41-7 | Isoquinoline,7-fluoro-3,4-dihydro-1-methyl-; 7-Fluoro-1-methyl-3,4-dihydroisoquinoline |  | C10H10FN | 詳情 | 供應商 | |